Last update:
Medications news
Medical research
Traditional Chinese medicinal fungi might show potential for central nervous system diseases
Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for central nervous system (CNS) diseases. Findings offer evidence for the potential of these fungi to serve ...
7 hours ago
0
13
Medications
Experimental compounds show promise for Alzheimer's and pain treatment in animal models
A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of Alzheimer's disease and pain, which have shown promising effects in animal models.
4 hours ago
0
19
Using an inhaler alone may not be enough to manage asthma
Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or "puffer").
6 hours ago
0
0

GSK buys liver disease drug for up to $2 bn
British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a common form of liver disease, in a deal worth up to $2 billion.
3 hours ago
0
0

Targeted approach to treating aggressive breast cancers shows significant improvement in survival
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.
May 13, 2025
0
51

No link between ADHD meds and psychosis, study says
ADHD stimulant meds don't increase children's risk of psychosis, a new study says.
May 13, 2025
0
0

Study finds long-term eczema treatment benefits patients with delayed response
New research from the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai reveals that patients with moderate-to-severe atopic dermatitis (eczema) who did not initially respond ...
May 13, 2025
0
0

Lower doses of the GLP-1 agonist medication as effective as higher ones, Danish study finds
New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials—but with less than half the ...
May 13, 2025
0
0

Interruptions disrupt pharmacy flow, risking safety
A new study has found that phone calls, face-to-face consumer inquiries and out-of-scope questions from staff are the main sources of distraction during the dispensing process in pharmacy settings.
May 13, 2025
0
0

Migraine drug can also help with symptoms that occur before the actual headache begins
A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding a migraine headache, according to the results of a large phase three clinical trial published in ...
May 12, 2025
0
172

Molecular approach prolongs ketamine's antidepressant effects in mice by weeks
Researchers at Vanderbilt University identified a molecular approach to extend the antidepressant effects of ketamine in mice by applying BCI, a compound that inhibits DUSP6 to sustain ERK pathway activation. Findings suggest ...

Drug to slow Alzheimer's well tolerated outside of clinical trial setting, study finds
The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression—was met with enthusiasm by many in the field as it represented ...
May 12, 2025
0
60

Social, cultural and economic status can affect risk of receiving risky medication
People with low wealth and income have up to 85% higher risk of receiving risky medication compared to the most affluent Danes. This is shown by a comprehensive national study led by researchers from Aarhus University, published ...
May 12, 2025
0
0

Zepbound outperforms Wegovy in head-to-head weight loss study
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy.
May 12, 2025
0
0

Mepolizumab yields lower rate of moderate/severe exacerbations in COPD
For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of moderate or severe exacerbations, ...
May 12, 2025
0
0

Do wellness patches work? How to tell the good from the bad
From sleep aids and stress relief to vitamins and energy boosts, wellness patches are surging in popularity. These stick-on supplements promise to deliver nutrients and plant-based compounds directly through your skin and ...
May 12, 2025
0
0

Trump announces drug price cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so they match those abroad, accusing Europe in particular of practices that force up prices for Americans.
May 12, 2025
0
0

Endometriosis: Daily pill to manage symptoms will soon be available on the NHS—here's how linzagolix works
A daily pill to treat endometriosis has just been recommended by the National Institute for Health and Care Excellence (Nice). Once available on the NHS, linzagolix will provide a new treatment option for those who have been ...
May 12, 2025
0
0

Opioid prescribing standards changed practices in British Columbia, but with caveats
In an effort to curb misuse of opioids and prevent overdose deaths, the College of Physicians and Surgeons of British Columbia released a legally enforceable practice standard, "Safe Prescribing of Drugs with Potential for ...
May 12, 2025
0
0

Foam treatment rapidly relieves itch and clears stubborn scalp psoriasis lesions
Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%. Findings indicated significantly higher ...

Cholesterol pill helps those at high risk of heart attack and stroke: Study
A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke.
May 9, 2025
0
84

Americans' use of illicit opioids is higher than previously reported, survey finds
More Americans use illicit opioids such as fentanyl than previously estimated, highlighting the need for better methods to understand the depths of the opioid crisis, according to a new study.
May 9, 2025
1
47

Weight-loss drugs cut alcohol intake by almost two-thirds, research in Ireland suggests
Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research presented at the European Congress on Obesity (ECO 2025) has found.
May 9, 2025
0
74

Fighting infections while expecting: Research examines safe antibiotic use during pregnancy
Pregnant women often think--or are told--that they cannot take medications during pregnancy to avoid harming the mom or baby. But one University of Mississippi professor is hoping new research will help medical professionals ...
May 9, 2025
0
1

When statins aren't enough, this drug may help lower 'bad' cholesterol
A new drug combo lowers "bad" LDL cholesterol for people whose levels remain high even after taking statins. The new pill pairs a new drug called obicetrapib with an existing one, ezetimibe. In a Phase 3 clinical trial, this ...
May 8, 2025
0
34
